Single Ascending Dose Study for Evaluation of Safety, Tolerability and Pharmacokinetics of L606
Status:
Completed
Trial end date:
2020-05-12
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the Pharmacokinetics, Safety and
Tolerability of L606 (Liposomal Treprostinil) Inhalation Solution in Single Ascending Dose
study design in healthy volunteers.